Suppr超能文献

miR-204:分子调控及其在心血管和肾脏疾病中的作用。

miR-204: Molecular Regulation and Role in Cardiovascular and Renal Diseases.

机构信息

Department of Physiology, Center of Systems Molecular Medicine, Medical College of Wisconsin, Milwaukee.

出版信息

Hypertension. 2021 Aug;78(2):270-281. doi: 10.1161/HYPERTENSIONAHA.121.14536. Epub 2021 Jun 28.

Abstract

The field of microRNA research has evolved from studies aiming to gauge the importance of microRNAs to those focusing on understanding a subset of specific microRNAs that have emerged as potent regulators of molecular systems and pathophysiological conditions. In this article, we review the molecular features and regulation of miR-204 and the growing body of evidence for an important role of miR-204 in the regulation of cardiovascular and renal physiology and pathophysiological processes. miR-204 exhibits a highly tissue-specific expression pattern, and miR-204 abundance is regulated by several transcriptional and posttranscriptional mechanisms. Strong evidence supports a role for miR-204 in attenuating pulmonary arterial hypertension and hypertensive and diabetic renal injury while promoting hypertension and endothelial dysfunction in a wide range of model systems. miR-204 may influence these disease processes by targeting several biological pathways in a tissue-specific manner. miR-204 is dysregulated in patients with cardiovascular and renal diseases. The unequivocal functional roles and clear clinical relevance indicate that miR-204 is a high-value microRNA in cardiovascular and renal diseases.

摘要

微小 RNA 研究领域已经从旨在评估微小 RNA 重要性的研究发展到专注于理解作为分子系统和病理生理状况的有效调节剂而出现的特定微小 RNA 亚类的研究。在本文中,我们回顾了 miR-204 的分子特征和调控,以及越来越多的证据表明 miR-204 在调节心血管和肾脏生理学和病理生理过程中的重要作用。miR-204 表现出高度组织特异性的表达模式,miR-204 的丰度受几种转录和转录后机制的调节。大量证据表明,miR-204 在减轻肺动脉高压和高血压及糖尿病肾损伤方面发挥作用,同时在广泛的模型系统中促进高血压和内皮功能障碍。miR-204 可能通过以组织特异性的方式靶向几种生物学途径来影响这些疾病过程。miR-204 在心血管和肾脏疾病患者中失调。明确的功能作用和明显的临床相关性表明,miR-204 是心血管和肾脏疾病中有价值的微小 RNA。

相似文献

2
Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases.miR-122 在心血管纤维化及相关疾病中的作用
Cardiovasc Toxicol. 2020 Oct;20(5):463-473. doi: 10.1007/s12012-020-09603-4. Epub 2020 Aug 27.
3
Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.综述:微小RNA在肾脏疾病病理生理学中的新作用
Am J Physiol Renal Physiol. 2016 Jan 15;310(2):F109-18. doi: 10.1152/ajprenal.00387.2015. Epub 2015 Nov 4.
5
MicroRNA-21 in cardiovascular disease.miRNA-21 在心血管疾病中的作用。
J Cardiovasc Transl Res. 2010 Jun;3(3):251-5. doi: 10.1007/s12265-010-9169-7. Epub 2010 May 1.
6
MiR-222 in Cardiovascular Diseases: Physiology and Pathology.心血管疾病中的MiR-222:生理学与病理学
Biomed Res Int. 2017;2017:4962426. doi: 10.1155/2017/4962426. Epub 2017 Jan 3.
7
MicroRNA-34a: role in cancer and cardiovascular disease.miRNA-34a:在癌症和心血管疾病中的作用。
Curr Drug Targets. 2014 Apr;15(4):361-73. doi: 10.2174/1389450115666140120102935.
8
Role of miR-107 and its signaling pathways in diseases.miR-107 及其信号通路在疾病中的作用。
J Recept Signal Transduct Res. 2014 Oct;34(5):338-41. doi: 10.3109/10799893.2014.896383. Epub 2014 Mar 6.

引用本文的文献

5
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.肺动脉高压:分子机制与临床研究
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.

本文引用的文献

1
Renal metabolism and hypertension.肾脏代谢与高血压。
Nat Commun. 2021 Feb 11;12(1):963. doi: 10.1038/s41467-021-21301-5.
2
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
9
Noncoding RNAs in Hypertension.高血压中的非编码RNA
Hypertension. 2019 Sep;74(3):477-492. doi: 10.1161/HYPERTENSIONAHA.119.13412. Epub 2019 Jul 29.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验